Zenith Epigenetics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 16

Employees

  • Stock Symbol
  • ZENI.P

Stock Symbol

  • Share Price
  • $0.04
  • (As of Wednesday Closing)

Zenith Epigenetics General Information

Description

Zenith Capital Corporation is a Capital Pool Company.

Contact Information

Website
www.zenithepigenetics.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 4820 Richard Road South West
  • Suite 300
  • Calgary, Alberta T3E 6L1
  • Canada
+1 (587)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
TSX
Vertical(s)
Life Sciences
Corporate Office
  • 4820 Richard Road South West
  • Suite 300
  • Calgary, Alberta T3E 6L1
  • Canada
+1 (587)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zenith Epigenetics Stock Performance

As of 04-Nov-2026, Zenith Epigenetics’s stock price is $0.04. Its current market cap is $317K with 7.39M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.04 $0.04 $0.04 - $0.07 $317K 7.39M 76.3K

Zenith Epigenetics Financials Summary

As of 30-Apr-2026, Zenith Epigenetics has a trailing 12-month revenue of null.

In Thousands,
USD 		TTM 30-Apr-2026 FY 2025 31-Jul-2025 FY 2024 31-Jul-2024 FY 2023 31-Jul-2023
EV 326 267
Revenue 0 0 0 0
EBITDA (35) (51) (136) (141)
Net Income (35) (51) (136) (141)
Total Assets 2 1 5 65
Total Debt 4 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Zenith Epigenetics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Zenith Epigenetics‘s full profile, request access.

Request a free trial

Zenith Epigenetics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Zenith Capital Corporation is a Capital Pool Company.
Biotechnology
Calgary, Canada
16 As of 2021

Tuebingen, Germany
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zenith Epigenetics Competitors (57)

One of Zenith Epigenetics’s 57 competitors is Immatics, a Formerly VC-backed company based in Tuebingen, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Immatics Formerly VC-backed Tuebingen, Germany
VBI Vaccines Corporation Cambridge, MA
Axsome Therapeutics Formerly VC-backed New York, NY
Denali Therapeutics Formerly VC-backed South San Francisco, CA
Takeda Pharmaceutical Corporation Tokyo, Japan
You’re viewing 5 of 57 competitors. Get the full list »

Zenith Epigenetics Patents

  • 198

    Total Documents Applications and Grants

  • Total Patents Families

  • 98

    Granted

  • 15

    Pending

  • Expiring in next 12 mo

Zenith Epigenetics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023049257-A1 Methods for treating triple-negative breast cancer in pre-selected patient populations with a combination of a bet bromodomain inhibitor and a parp inhibitor Inactive 23-Sep-2021
JP-2022500423-A Combination therapy for the treatment of estrogen receptor-positive breast cancer Active 13-Sep-2018
JP-7441213-B2 Combination therapy for the treatment of estrogen receptor-positive breast cancer Active 13-Sep-2018
CA-3110788-A1 Combination therapy for the treatment of estrogen-receptor positive breast cancer Pending 13-Sep-2018
EP-3849550-A1 Combination therapy for the treatment of estrogen-receptor positive breast cancer Active 13-Sep-2018 A61K31/437
To view Zenith Epigenetics’s complete patent history, request access »

Zenith Epigenetics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zenith Epigenetics ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Diversified Financials

Industry

Rank

Percentile

Asset Management and Custody Services

Subindustry

Rank

Percentile

To view Zenith Epigenetics’s complete esg history, request access »

Zenith Epigenetics FAQs

  • When was Zenith Epigenetics founded?

    Zenith Epigenetics was founded in 2013.

  • Where is Zenith Epigenetics headquartered?

    Zenith Epigenetics is headquartered in Calgary, Canada.

  • What is the size of Zenith Epigenetics?

    Zenith Epigenetics has 16 total employees.

  • What industry is Zenith Epigenetics in?

    Zenith Epigenetics’s primary industry is Biotechnology.

  • Is Zenith Epigenetics a private or public company?

    Zenith Epigenetics is a Public company.

  • What is Zenith Epigenetics’s stock symbol?

    The ticker symbol for Zenith Epigenetics is ZENI.P.

  • What is the current stock price of Zenith Epigenetics?

    As of 04-Nov-2026 the stock price of Zenith Epigenetics is $0.04.

  • What is the current market cap of Zenith Epigenetics?

    The current market capitalization of Zenith Epigenetics is $317K.

  • Who are Zenith Epigenetics’s competitors?

    Immatics, VBI Vaccines, Axsome Therapeutics, Denali Therapeutics, and Takeda Pharmaceutical are some of the 57 competitors of Zenith Epigenetics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process